Indication
Campylobacter fetus infection
Campylobacter fetus infection is an opportunistic, zoonotic bacterial disease caused by the gram-negative bacillus *Campylobacter fetus*. Read more about Campylobacter fetus infection
176 drugs 94 manufacturers
Drugs that treat it
Common Campylobacter fetus infection therapies.
DOXYCYCLINE MONOHYDRATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
MINOCYCLINE (minocycline HCl)
LYMEPAK (doxycycline hyclate)
VIBRAMYCIN (MONO) (doxycycline monohydrate)
MINOCYCLINE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCampylobacter fetus infection is an opportunistic, zoonotic bacterial disease caused by the gram-negative bacillus *Campylobacter fetus*.
Unlike other *Campylobacter* species that primarily produce self-limiting diarrheal illness, *Campylobacter fetus* possesses a protective surface layer protein capsule that resists complement-mediated phagocytosis, conferring a marked propensity for bacteremia and systemic dissemination.
The infection predominantly affects immunocompromised individuals, elderly adults, and patients with pre-existing cardiovascular conditions, often presenting with nonspecific fevers or focal, endovascular manifestations.
Defining clinical features include sustained bacteremia, infective endocarditis, mycotic aneurysms, septic thrombophlebitis, and, in pregnant patients, adverse outcomes such as chorioamnionitis and spontaneous abortion.
- cdc.gov
Campylobacter fetus infection is an opportunistic, zoonotic bacterial disease caused by the gram-negative bacillus *Campylobacter fetus*
- nih.gov
Campylobacter fetus infection is an opportunistic, zoonotic bacterial disease caused by the gram-negative bacillus *Campylobacter fetus* Defining clinical features include sustained bacteremia, infective endocarditis, mycotic aneurysms, septic thrombophlebitis, and, in pregnant patients, adverse outcomes such as chorioamnionitis and spontaneous abortion
- nih.gov
Unlike other *Campylobacter* species that primarily produce self-limiting diarrheal illness, *Campylobacter fetus* possesses a protective surface layer protein capsule that resists complement-mediated phagocytosis, conferring a marked propensity for bacteremia and systemic dissemination
- youtube.com
Unlike other *Campylobacter* species that primarily produce self-limiting diarrheal illness, *Campylobacter fetus* possesses a protective surface layer protein capsule that resists complement-mediated phagocytosis, conferring a marked propensity for bacteremia and systemic dissemination
- nih.gov
The infection predominantly affects immunocompromised individuals, elderly adults, and patients with pre-existing cardiovascular conditions, often presenting with nonspecific fevers or focal, endovascular manifestations
- nih.gov
The infection predominantly affects immunocompromised individuals, elderly adults, and patients with pre-existing cardiovascular conditions, often presenting with nonspecific fevers or focal, endovascular manifestations
- nih.gov
Defining clinical features include sustained bacteremia, infective endocarditis, mycotic aneurysms, septic thrombophlebitis, and, in pregnant patients, adverse outcomes such as chorioamnionitis and spontaneous abortion
Personalize your experience
Follow Campylobacter fetus infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.